OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Endocrinology Diabetes and Obesity is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
The therapeutic properties of ketogenic diets, slow-wave sleep, and circadian synchrony	30
Maximizing diabetes education efforts in vulnerable populations – newer delivery concepts	30
Public health concerns and increased risk of severe COVID-19 disease through androgen use	28
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and thyroid disease. An update	26
Utilizing type 2 diabetes medications outside glycemic parameters – where are we headed?	26
Editorial: Health considerations across the lifespan for patients with polycystic ovary syndrome	22
Updates in thyroid healthcare delivery: advancing patient-centered care	21
Advances in the care of lipodystrophies	20
Bone accrual in children and adolescents with type 1 diabetes: current knowledge and future directions	20
Nutrition and thyroid disease	20
The female athlete triad: review of current literature	20
MR-based techniques for intracortical vessel visualization and characterization: understanding the impact of microvascular disease on skeletal health	19
Editorial introduction	18
Advances in assessment and treatment of bone, mineral and parathyroid disorders	18
Prevalence and correlates of androgen dependence: a meta-analysis, meta-regression analysis and qualitative synthesis	17
Recent advances in anaplastic thyroid cancer management	17
International patient group harnesses social media to help inform rare disease research: use of a low carbohydrate ketogenic diet in McArdle disease	17
Editorial	17
Appropriate selection of candidates for outpatient thyroidectomy	16
Editorial introductions	16
Financial toxicity in thyroid cancer survivors	16
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?	15
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare	15
Interactions between antidiabetes medications and heart–brain axis	14
Editorial introduction	14

Medullary thyroid carcinoma	14
Preventing type 1 diabetes development and preserving beta-cell function	14
The use of anabolic agents in the treatment of osteoporosis: a clinical update	13
Gastrointestinal hormones and regulation of gastric emptying	13
Targeting apolipoprotein C-III: a game changer for pancreatitis prevention in severe hypertriglyceridemia	12
Bone marrow fibrocytes: villain or white knight in thyroid-associated ophthalmopathy?	12
The role for long-term use of dehydroepiandrosterone in adrenal insufficiency	12
Update on fracture risk assessment in osteoporosis	12
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks	12
An update on bone in diabetes	12
Fibrous dysplasia in children and its management	12
New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease	11
Long-acting amylin analogues for the management of obesity	11
Assisted reproductive technology outcomes and management considerations for people with epilepsy	11
Epidemiologic changes in thyroid disease	11
Growth and development in type 1 diabetes	11
Lipidomics in diabetes	11
Precision medicine in diabetes care	10
Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders	10
TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease	10
A short history of saturated fat: the making and unmaking of a scientific consensus	9
Type 2 diabetes: a contemporary view from the Asian lens	9
Legislation, medicine, and politics: care for gender diverse youth	9
The uncommon forms of congenital adrenal hyperplasia	9
An update on investigation and management of renal bone disease	9
Glucocorticoid withdrawal syndrome: what to expect and how to manage	9
Adrenal insufficiency and pregnancy	9
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation	8
Effects of marijuana on reproductive health: preconception and gestational effects	8
Editorial introductions	8
Retrospective cohort study of changes in estimated glomerular filtration rate for patients prescribed a low carb diet	8
Editorial introductions	8
Survival benefit of endocrine dysfunction following immune checkpoint inhibitors for nonthyroidal cancers	7
Editorial introductions	7
Androgen abuse among gay and bisexual men	7
Novel techniques for assessment of bone tissue material properties	7
Early anthropometric indicators of type 2 diabetes mellitus	7
The interaction between gut microbiome and bone health	7
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experiment	7
Time to cycle regularity and health risks	7
An Update on Vitamin D Deficiency in the twenty-first century: nature and nurture	7
Treating obesity in type 1 diabetes mellitus – review of efficacy and safety	6
Advanced imaging and theranostics in thyroid cancer	6
Type 2 diabetes mellitus and cognitive function: understanding the connections	6
Polygenic risk scores for the diagnosis and management of dyslipidemia	6
Multifactorial chylomicronemia syndrome	6
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective	6
Microplastics, cardiometabolic risk, genetics and Alzheimer's disease	6
Continuous glucose monitoring in primary care – are we there?	6
Assessing the contribution of plastic-associated obesogenic compounds to cardiometabolic diseases	6

Indications for testosterone therapy in men	6
Novel delivery mechanisms for antigen-specific immunotherapy	6
The psychosocial impact of thyroid cancer	6
The 1 mg overnight dexamethasone suppression test: a danger to the adrenal gland?	6
Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management	6
Editorial introductions	5
Gastrointestinal regulatory peptides	5
Predictors of cardiovascular risk in familial hypercholesterolemia	5
When history, law, and medicine intersect	5
Radiofrequency ablation (RFA) compared to observation for benign thyroid nodules: emerging considerations for judicious use	5
Current state of antigen-specific immunotherapy for type 1 diabetes	5
Editorial introductions	5
Bridging the LatinX community care gap	5
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials	5
Gestational diabetes and other adverse pregnancy outcomes in polycystic ovary syndrome	5
Skeletal health in diabetes	4
Aggression and criminality in androgen abusers	4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes	4
Mixed-methods research on androgen abuse – a review	4
Fracture prediction tools in diabetes	4
Editorial: New horizons for thyroid diseases: transformative changes and tailored care	4
Treatment of bone fragility in patients with diabetes: antiresorptive versus anabolic?	4
Prediabetes and skeletal health	4
HDL functionality in type 1 and type 2 diabetes: new insights	4
Recent advances in the role of miRNAs in bone disease	4
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?	4
Nutritional ketosis is well-tolerated, even in type 1 diabetes: the ZeroFive100 Project; a proof-of-concept study	4
Bone marrow adiposity in diabetes and clinical interventions	3
Future studies using histomorphometry in type 1 diabetes mellitus	3
Cardiovascular disease in metabolic-associated fatty liver disease	3
Better care for women with polycystic ovary syndrome – a proposal for an international evidence based best practice framework to improve care	3
Editorial introductions	3
Utilizing point-of-care A1c to impact outcomes – can we make it happen in primary care?	3
Update on management of paediatric dyslipidaemia	3
Hypoparathyroidism update	3
Body composition in sexual precocity	3
Growth and development in monogenic forms of neonatal diabetes	3
Potassium-competitive acid blockers and acid-related disorders	3
Editorial: Childhood endocrine and genetic disorders: improving adult outcomes	3
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms	3
Coronary artery event-free or resilient familial hypercholesterolemia: what's in a name?	3
Use of calculated free testosterone in men: advantages and limitations	2
Use of anti-Müllerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome	2
Differences in the management of thyroid nodules in children and adolescents as compared to adults	2
Emerging treatment for congenital adrenal hyperplasia	2
Selective progesterone receptor modulators and reproductive health	2
Ketogenic diet as an advanced option for the management of pediatric obesity	2
Molecular testing for indeterminate thyroid nodules: past, present, and future	2
Addressing genetic and environmental sources of cardiometabolic disease	2
Benefits and risks of apps for patients	2
Under and overtreatment with thyroid hormone replacement during pregnancy	2
Mouse models of type 1 diabetes and their use in skeletal research	2
Health effects of androgen abuse: a review of the HAARLEM study	2
Editorial: Bone health in type 1 and type 2 diabetes: current knowledge and future direction	2
Effect of incretins on skeletal health	2
Enteroendocrine cell differentiation and function in the intestine	2
Editorial introduction	2
Editorial overview	2
Editorial introductions	2
Eicosapentaenoic acid vs. docosahexaenoic acid for the prevention of cardiovascular disease	2
Glucagon-like peptide-1 receptor agonists and safety in the preconception period	2
Acromegaly: achieving timely diagnosis and improving outcomes by personalized care	2
Overview of diabetes agents in cardiovascular disease: it takes an orchestra to play Tchaikovsky in symphony	2
An update: maternal iodine supplementation, thyroid function tests, and child neurodevelopmental outcomes	2
Sleep disruptions and bone health: what do we know so far?	2
Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?	2
Molecular tools for diagnosing diseases of the adrenal cortex	2
Editorial introductions	2
Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia	2
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes	2